IL231410A0 - Endoglycosidase from Streptococcus pyogenes and methods of using it - Google Patents

Endoglycosidase from Streptococcus pyogenes and methods of using it

Info

Publication number
IL231410A0
IL231410A0 IL231410A IL23141014A IL231410A0 IL 231410 A0 IL231410 A0 IL 231410A0 IL 231410 A IL231410 A IL 231410A IL 23141014 A IL23141014 A IL 23141014A IL 231410 A0 IL231410 A0 IL 231410A0
Authority
IL
Israel
Prior art keywords
endoglycosidase
methods
streptococcus pyogenes
pyogenes
streptococcus
Prior art date
Application number
IL231410A
Other languages
English (en)
Hebrew (he)
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genovis Ab filed Critical Genovis Ab
Publication of IL231410A0 publication Critical patent/IL231410A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL231410A 2011-09-13 2014-03-09 Endoglycosidase from Streptococcus pyogenes and methods of using it IL231410A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201115841A GB201115841D0 (en) 2011-09-13 2011-09-13 Protein and method
PCT/EP2012/067841 WO2013037824A1 (en) 2011-09-13 2012-09-12 Endoglycosidase from streptococcus pyogenes and methods using it

Publications (1)

Publication Number Publication Date
IL231410A0 true IL231410A0 (en) 2014-04-30

Family

ID=44908522

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231410A IL231410A0 (en) 2011-09-13 2014-03-09 Endoglycosidase from Streptococcus pyogenes and methods of using it

Country Status (20)

Country Link
US (1) US9493752B2 (OSRAM)
EP (1) EP2756077B1 (OSRAM)
JP (1) JP6076349B2 (OSRAM)
KR (1) KR102001427B1 (OSRAM)
CN (1) CN103946377B (OSRAM)
AU (1) AU2012307461B2 (OSRAM)
BR (1) BR112014005816A2 (OSRAM)
CA (1) CA2848230C (OSRAM)
DK (1) DK2756077T3 (OSRAM)
EA (1) EA028490B8 (OSRAM)
ES (1) ES2627334T3 (OSRAM)
GB (2) GB201115841D0 (OSRAM)
IL (1) IL231410A0 (OSRAM)
IN (1) IN2014CN02163A (OSRAM)
MX (1) MX347727B (OSRAM)
PL (1) PL2756077T3 (OSRAM)
PT (1) PT2756077T (OSRAM)
SG (1) SG11201400505YA (OSRAM)
WO (1) WO2013037824A1 (OSRAM)
ZA (1) ZA201401840B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307564T3 (es) * 2000-12-21 2008-12-01 Id Biomedical Corporation Antigenos de streptococcus pyrogenes y fragmentos de adn correspondientes.
LT3912642T (lt) 2012-10-23 2023-07-25 Synaffix B.V. Modifikuotas antikūnas, antikūno konjugatas ir jų gamybos būdas
ES2759503T3 (es) 2013-05-02 2020-05-11 Glykos Finland Oy Conjugados de una glicoproteína o un glicano con una carga útil tóxica
WO2015057064A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
JP2016538877A (ja) 2013-10-14 2016-12-15 シンアフィックス ビー.ブイ. 修飾糖タンパク質、タンパク質コンジュゲート及びそれらの調製方法
EP2935611B1 (en) 2013-10-14 2021-07-07 SynAffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
WO2015057065A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
GB201318490D0 (en) * 2013-10-18 2013-12-04 Genovis Ab Method
CN106660967A (zh) 2014-01-24 2017-05-10 西纳福克斯股份有限公司 (杂)芳基1,3‑偶极化合物与(杂)环炔的环加成方法
EP3682904A1 (en) 2014-06-30 2020-07-22 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
CN107109454A (zh) 2014-08-04 2017-08-29 西纳福克斯股份有限公司 用β‑(1,4)‑N‑乙酰半乳糖胺转移酶或其突变体修饰糖蛋白的方法
GB201502306D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
HRP20180439T1 (hr) 2015-04-23 2018-07-13 Synaffix B.V. Postupak modificiranja glikoproteina glikoziltransferazom koja je ili je derivat beta-(1,4)-n-acetilgalaktozaminil transferaze
WO2017124084A1 (en) * 2016-01-15 2017-07-20 University Of Maryland, College Park Endo-s2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
DK3411389T3 (da) 2016-02-04 2021-06-21 Genovis Ab Nye streptokokproteaser
AU2017315677B2 (en) * 2016-08-24 2021-03-11 Academia Sinica Endoglycosidase mutants for glycoprotein remodeling and methods of using it
PT3630968T (pt) 2017-05-26 2024-07-30 Genovis Ab Enzimas para análise de glicanos
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
WO2019243672A1 (en) 2018-06-19 2019-12-26 Glykos Biomedical Oy Conjugate
JP2021529163A (ja) 2018-06-29 2021-10-28 グリコス バイオメディカル オーワイ コンジュゲート
WO2021123506A1 (en) 2019-12-18 2021-06-24 Glykos Biomedical Oy Stabile conjugate
CN111044731B (zh) * 2019-12-19 2021-05-07 北京科技大学 脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
BR112022013255A2 (pt) 2020-01-09 2022-09-06 Mersana Therapeutics Inc Conjugados anticorpo-fármaco específicos de sítio com ligantes contendo peptídeo
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
JP2023541698A (ja) * 2020-09-21 2023-10-03 上海宝済薬業有限公司 組合せ医薬及びその使用
KR20230137339A (ko) 2021-01-04 2023-10-04 메르사나 테라퓨틱스, 인코포레이티드 B7h4-표적화된 항체-약물 접합체 및 이의 사용 방법
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
CN115873833B (zh) * 2022-11-08 2024-08-16 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺
CN117165643B (zh) * 2023-08-17 2025-10-28 山东大学 一种糖苷内切酶在水解高甘露糖型n-糖蛋白中的应用
TW202519652A (zh) * 2023-11-10 2025-05-16 大陸商上海齊魯製藥研究中心有限公司 新型Endo S2突變體酶

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
JP5722627B2 (ja) * 2007-09-14 2015-05-27 ジェノビス エービー FCガンマ受容体−IgG複合体の解離、ならびにIgGの精製および検出のための方法およびキット
GB0821100D0 (en) 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
EP2483693B1 (en) * 2009-10-02 2014-12-03 Roche Glycart AG A-fucosylation detection in antibodies

Also Published As

Publication number Publication date
ES2627334T3 (es) 2017-07-27
CN103946377B (zh) 2016-10-05
GB2509284A (en) 2014-06-25
JP6076349B2 (ja) 2017-02-08
EA201490447A1 (ru) 2014-09-30
AU2012307461A1 (en) 2014-03-27
DK2756077T3 (en) 2017-07-03
GB201115841D0 (en) 2011-10-26
CA2848230C (en) 2020-03-24
MX2014002906A (es) 2014-10-17
KR102001427B1 (ko) 2019-07-18
PL2756077T3 (pl) 2017-09-29
MX347727B (es) 2017-05-10
IN2014CN02163A (OSRAM) 2015-05-29
US20140302519A1 (en) 2014-10-09
EP2756077A1 (en) 2014-07-23
GB201406321D0 (en) 2014-05-21
WO2013037824A1 (en) 2013-03-21
SG11201400505YA (en) 2014-04-28
ZA201401840B (en) 2018-05-30
CN103946377A (zh) 2014-07-23
BR112014005816A2 (pt) 2020-12-29
EA028490B8 (ru) 2018-01-31
NZ622172A (en) 2016-04-29
EP2756077B1 (en) 2017-03-29
JP2014531205A (ja) 2014-11-27
KR20140081813A (ko) 2014-07-01
US9493752B2 (en) 2016-11-15
CA2848230A1 (en) 2013-03-21
AU2012307461B2 (en) 2016-08-18
EA028490B1 (ru) 2017-11-30
PT2756077T (pt) 2017-06-21

Similar Documents

Publication Publication Date Title
ZA201401840B (en) Endoglycosidase from streptococcus pyogenes and methods using it
GB201107863D0 (en) Method and product
ZA201309700B (en) Electrodesalination system and method
GB201117278D0 (en) Method and system
GB201101966D0 (en) Infrastructure equipmnet and method
IL230511A0 (en) 4-Imidazopyridazine-1-yl-benzamides and 4-imidazotriazine-1-yl-benzamides as btk inhibitors
GB201011971D0 (en) Methods and product
GB2505169B (en) decoder and method
GB201110783D0 (en) Methods and uses
GB201104983D0 (en) Receiver and method
GB201118985D0 (en) Product and method
GB201122089D0 (en) Telecomunication apparatus and methods
GB201113610D0 (en) Product and method
EP2727068A4 (en) DYNAMIC UPDATE SYSTEM AND METHOD
GB201121406D0 (en) Systems and methods
EP2729906A4 (en) SYSTEMS AND METHOD FOR PRODUCT CONFIGURATION
GB201112981D0 (en) An arrangement and method
GB201116774D0 (en) Uses and methods
ZA201400067B (en) Chainage calculation methodology and system
GB201401983D0 (en) Loyalty systems and methods
GB201105569D0 (en) Apparatus and methods
GB201112970D0 (en) An arrangement and method
GB2502227B (en) Audio association systems and methods
GB201104534D0 (en) Receiver and methods
GB201108490D0 (en) Methods and uses